Table 1 Results of antibiotic susceptibility tests of the V. parahaemolyticus (Vp) strains. Strains were resistant (R) or susceptible (S) to the antibiotics or showed an intermediate (I) profile. Identified ARGs, supporting the observed resistance phenotypes are included. A visual overview of all identified ARGS is given in Additional file 2
Antibiotic class | Antibiotic | Vp M0904 | Vp TW01 | Vp PV1 |
|---|---|---|---|---|
Β-lactam | ||||
- Penams | ampicillin (10 µg) | R blaCARB-23 | R blaCARB-21 | R blaCARB-23 |
amoxicillin-clavulanate (20/10 µg) | S | S | S | |
ampicillin-sulbactam (10/10 µg) | S | S | S | |
piperacillin (100 µg) | R blaCARB-23 | I blaCARB-21 | I blaCARB-23 | |
- Cephalosporins | cefotaxime (30 µg) | S | S | S |
ceftazidime (30 µg) | S | S | S | |
Aminoglycosides | amikacin (30 µg) | S | S | S |
gentamicin (10 µg) | S | S | S | |
Tetracyclines | tetracycline (30 µg) | R tet(B) | S | S |
Fluoroquinolones | ciprofloxacin (5 µg) | S | S | S |
levofloxacin (5 µg) | S | S | S | |
ofloxacin (5 µg) | S | S | S | |
Folate pathway inhibitors | trimethoprim-sulfamethoxazole (5 µg) | R dfrA6 | S | S |